Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2019 Jan 21;19:97. doi: 10.1186/s12885-019-5297-x

Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

Jeremie Calais 1,, Johannes Czernin 1,, Wolfgang P Fendler 1,2, David Elashoff 3, Nicholas G Nickols 4,5
PMCID: PMC6341574  PMID: 30665383

Correction to: BMC Cancer

https://doi.org/10.1186/s12885-018-5200-1

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.

  • Originally published name:
    • Nicholas Nicholas G. Nickols
  • Correct name:
    • Nicholas G. Nickols

Contributor Information

Jeremie Calais, Email: jcalais@mednet.ucla.edu.

Johannes Czernin, Email: jczernin@mednet.ucla.edu.

Reference

  • 1.Calais, et al. Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT] BMC Cancer. 2018;19:18. doi: 10.1186/s12885-018-5200-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES